Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price

AMPHStock
$22.0127.26%52W
Market Cap$936.26M
P/E8.75x
PEG Ratio0.08
Div yield
Beta0.92

AMPH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-32.39%
Price vs S&P 500 (4W)7.31%
PEG Ratio0.08
VGM Score66.51
P/E Ratio (Annual)8.75x

AMPH Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$0.61$0.91+48.26%(+$0.30)
Q1 2026$0.71$0.42-40.46%(-$0.29)
Q4 2025$0.92$0.73-20.50%(-$0.19)
Q3 2025$0.83$0.93+12.68%(+$0.10)
Q2 2025$0.74$0.85+14.62%(+$0.11)

AMPH Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.69
2.58
2.50
2.50

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
AMPHAmphastar Pharmaceuticals, Inc.
ABC$22.01
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals manufactures generic and proprietary injectable, inhalation, intranasal, and insulin products for hospitals and urgent care settings. Its products are distributed through group purchasing organizations and drug wholesalers, with operations primarily in the United States and supplemented by facilities in China and France.